Hologic Expands Panther Fusion's Menu With Diagnostic Innovation

HOLX expands its Panther Fusion platform with new GI bacterial assays, securing FDA and EU approvals to boost Diagnostics growth.
Cadillac News

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

(Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for the Panther ...
Medical Device Network on MSN

Hologic gains FDA clearance for GI pathogen detection assays

The US Food and Drug Administration (FDA) has cleared Hologic’s first gastrointestinal (GI) pathogen detection tests.
Nasdaq

HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests

Hologic, Inc. HOLX recently received FDA 510(k) clearance for its Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. Additionally, the assays obtained CE marking in the ...